While elevated tumor COX2 expression was also predictive of a poor outcome as defined by HR of 2.45 in ER- patients from the same cohort [9], elevated NOS2/COX2 coexpression was strongly predictive of poor outcome (HR 21) [10]. The gene discussed is NOS2; the disease is neoplasm.